Trial Profile
A Randomised, Double-blind, Placebo-controlled Study of Topical GW870086X Formulation in Subjects With Moderate or Severe Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs GSK 870086 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors GSK
- 22 Dec 2014 New trial record